Plain-English translation of NCT05030818 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial tests whether Trinomia® polypill — a single tablet containing three heart medications (aspirin, a cholesterol drug, and a blood pressure medication) — works just as well as taking those same three medications separately. The study will measure how effectively each approach controls blood pressure, cholesterol levels, and blood clotting in people with coronary artery disease.
Taking multiple pills every day is hard, and many people skip doses or forget their medications. This medication was designed to make treatment simpler by combining three necessary drugs into one pill, so researchers want to confirm it works as well as the separate pills while making it easier for patients to stay on their treatment.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic once per month for 6 months. For the first 3 months, you'll take the combination pill, and for the remaining 3 months, you'll take the same three medications as separate pills (at the same doses). At each visit, the doctors will check your blood pressure, cholesterol levels, and blood clotting, and ask how you're feeling and whether you're taking your medications as prescribed.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Spain